India 2030: Who Supplies the Next 10 Million?

India, Nov. 1 -- image credit- shutterstock The battle for India's diabetes market is no longer simply about who sells the most insulin. It is about who can reach more patients, make treatment afford... Read More

Can India accelerate ocular healthcare with AI?

India, Nov. 1 -- image credit- freepik As per reports, glaucoma has emerged as a major public health challenge in India, currently affecting over 12 million people, most of whom remain undiagnosed. B... Read More

India's Neurotech Startups Take Brain Science from Lab to Market

India, Nov. 1 -- image credit- freepik For decades, neuroscience in India largely remained within hospitals, universities and research laboratories. The brain was difficult to measure, harder to trea... Read More

Cancer Drug Price Reset: NPPA Tightens Compliance as Supreme Court Eyes Wider Controls

India, Nov. 1 -- image credit- shutterstock The affordability of medicines in India has come under renewed scrutiny after the Supreme Court (SC) questioned the wide gap between procurement prices and... Read More

"Pricing needs to be considered carefully in the context of the global market"

India, Nov. 1 -- How will the Centre's decision to cap trade margins on non-scheduled anti-cancer medicines affect drug pricing and distribution in India? The order seeks to rationalise the trade mar... Read More

Beyond the Spin: Can Indian Centrifuge Makers Move Up the Technology Curve?

India, Nov. 1 -- image credit- freepik A centrifuge is among the most familiar instruments in a laboratory, but the business of centrifugation is becoming increasingly sophisticated. Pharmaceutical c... Read More

"A key priority is to look beyond the cost of medicines and strengthen the entire oncology-care pathway, particularly screening, early diagnosis and timely treatment"

India, Nov. 1 -- Will the 30 per cent trade-margin cap materially improve cancer-care affordability, and what could limit its impact? The NPPA's decision to cap trade margins at 30 per cent for 137 a... Read More

"Indian centrifuge market is increasingly moving from price-driven to value- and trust-driven buying"

India, Nov. 1 -- How has demand for centrifuges in India changed over the last 2-3 years, and which segments are driving the strongest growth? Over the last couple of years, we have seen strong and s... Read More

"The biggest challenges in sourcing synthetic DNA are turnaround time, customisation, logistics and supply reliability"

India, Nov. 1 -- What prompted you to partner with DNA Script, and what market opportunity do you see for on-demand DNA synthesis in India? Imperial Life Sciences saw a strong opportunity because Ind... Read More

Beyond Centralised vs Distributed: India's Emerging MRD Model

India, Nov. 1 -- The minimal residual disease (MRD) testing market, one of the fastest-growing segments of the global diagnostics industry, has reached an inflection point. The defining question is no... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»